Stay updated on ILIxadencel + CPI in Tumors Clinical Trial
Sign up to get notified when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.

Latest updates to the ILIxadencel + CPI in Tumors Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 is displayed on the page, replacing v3.3.3. This is a minor version update with no changes to the trial details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now includes a dedicated Locations section listing Florida, Iowa, Kentucky, North Carolina, and Ohio. The HHS Vulnerability Disclosure link and the former state-specific location sections were removed, and the revision tag was updated to v3.3.3.SummaryDifference0.6%

- Check55 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.2; no user-visible content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe funding/operating-status notice at the top of the page was removed; the study details and related information remain unchanged.SummaryDifference0.3%

- Check76 days agoChange DetectedNo significant additions or deletions were detected on the page; the page content and structure appear unchanged.SummaryDifference0.4%

- Check105 days agoChange DetectedIn short: the page adds a government-funding operating-status notice and a new version tag (v3.2.0), and removes a specific resource topic (Squamous cell carcinoma of the head and neck) and the older version tag (v3.1.0).SummaryDifference4%

Stay in the know with updates to ILIxadencel + CPI in Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.